Displaying items by tag: research

UAB study suggests individuals diagnosed with autism spectrum disorder may not be more prone to cyber phishing attacks compared to those without the disorder.
A UAB dentist has developed a new filling using antibiotics and nitric oxide for root canal treatment that can help heal the canal more effectively.
In two new studies, a UAB oncologist explores questions of choice and cost in metastatic breast cancer.
This knowledge can provide targets in the search for novel bone-loss therapeutics to treat osteoporosis.
Researchers have discovered the mechanism of this control, with implications for developmental biology, the immune response and cancer dysregulation.
The August issue of the journal focused on genomics in rheumatic diseases, the complex effort to understand the genetic underpinnings of more than 100 diseases that affect joints and muscles.
This novel method improves purification of complex proteins by 10- to 500-fold, and it may aid both research and large-scale industrial production.
Michael Birrer, a leading medical oncologist at Harvard University, will take the reins as the new director of the UAB Comprehensive Cancer Center, succeeding the retiring Edward Partridge.
At a time when medical cannabis and cannabis-based products are gaining traction in the treatment of seizures, one of UAB’s CBD oil investigators serves as a guest editor for a special research journal devoted to cannabinoid research.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
A UAB symposium on cardiovascular tissue engineering brought together some of the best in the business in this rapidly developing field of translational medicine.
The first target for the UAB spinoff Incysus Ltd. will be glioblastoma. Incysus has just received a European patent for its innovative approach to fighting cancer.
Page 5 of 57